If it is the drug (or “the medicine”) that is doing the work, rather than The Container - then it is a slippery slope to a fully AI-powered “support” system of therapy-gpt chatbots, fluffy articles about integration, and a skeleton crew of disengaged NPs and PAs prescribing a brick wall of 10 min appointments, 7 days a week.
The big picture: While research continues, psychedelic medicine could reshape the future of healthcare and wellness. As momentum builds, scientists, startups, investors, and big pharma are plotting their next move.
It’s tempting to group psychedelics companies like COMPASS in with the “green wave” of cannabis companies that have taken the market by storm starting with Tilray’s IPO in July 2018. But psychedelics companies like COMPASS are less like cannabis companies, which have mainly focused on recreational use, and more like biotech stocks focused on the ha... See more